Multiple Assemblies exist for SMTL entry 4xs2
Irak4-inhibitor co-structure; X-RAY DIFFRACTION 2.73 Å

	SMTL ID 4xs2.1 Ligands (1R,2S,3R,5R)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-[(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydroxymethyl)cyclopentane-1,2-diol Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4xs2.2 Ligands (1R,2S,3R,5R)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-[(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydroxymethyl)cyclopentane-1,2-diol Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4xs2.3 Ligands (1R,2S,3R,5R)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-[(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydroxymethyl)cyclopentane-1,2-diol Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4xs2.4 Ligands (1R,2S,3R,5R)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-[(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydroxymethyl)cyclopentane-1,2-diol Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer